Base to Base biotech podcast 12: CLS boosts drug discovery capabilities, and Sitryx – pioneers in immunometabolism
Base to Base Biotech por Jim Cornall
Notas del episodio
This week, our guests are Ben Cliff, CEO of UK-based CRO, Concept Life Sciences, and Ravi Rao, chief medical officer of Sitryx.
Interview times
01:12 Sitryx
19:40 CLS
Concept Life Sciences
Concept Life Sciences (CLS), a provider of drug discovery, development, and manufacturing services to the global pharma and biotech sector, recently announced an investment into its drug discovery capabilities.
CLS is the UK’s biggest independent CRO, employing over 250 people, and with a corporate heritage spanning 25 years. Its recent strategic investment in the automation of its ADME (absorption, distribution, metabolism, excretion) which supports clients with medicinal chemistry in complex R& ...
Palabras clave
biotechbiotechnologyautoimmune diseaseinflammatory diseaseCROSitryxConcept Life Sciences